CV CapsoVision, Inc.: Market Capitalization to Book Value Ratio

Official company branding of CapsoVision, Inc. (CV)

The price action of CapsoVision Inc (CV) demonstrates the impact of outsourcing capsule production, allowing the company to focus on R&D. The potential for business expansion through cost reduction as orders increase is captured at 26.60. Revenue stability is supported by low sensitivity to crises and the natural aging of the population, which guarantees constant demand for gastrointestinal examinations.

CapsoVision - CV Market Value to Equity Ratio (period 07/03/2025 - 10/26/2026)
Brand item of capsovision.com

Professional capital evaluates the profile of CapsoVision Inc (CV) through the lens of the market-to-book value premium, determining the degree of business overvaluation relative to its balance sheet. Analyzing the market value to book value ratio dynamics on GURU.Markets allows for a comparison between market expectations for unique 360-degree endoscopy and the actual value of resources, confirming the fundamental stability and absence of hidden asset impairment for CapsoVision Inc (CV).

Competitor analysis

Abbott Laboratories - Market Capitalization to Book Value Ratio|thermofisher.com (TMO) - Market Capitalization to Book Value|GEHC (GE HealthCare Technologies) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio Mettler-Toledo|WAT: Market Capitalization to Book Value Ratio|Market Value to Equity Ratio TECH (Bio-Techne Inc.)|BRKR - Market Value to Book Value Ratio|azenta.com - Capitalization to Book Value Ratio|VREX (Varex Imaging Corporation) - Market Value to Book Value Ratio|SMLR: Market-to-Book Ratio|Butterfly iQ - Market Value to Book Value Ratio|Market Capitalization to Book Value Mesa Laboratories Corp.|Quantum-Si (QSI) - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple nanox.vision|QTRX (Quanterix) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value 908 Devices Inc (MASS)|MaxCyte, Inc - Market Capitalization to Book Value Ratio|RPID - Market Cap to Net Assets Ratio|Market Cap to Net Assets Ratio Seer, Inc. (SEER)|HYPR: Market Value to Book Value|FONR (FONAR) - Market Value to Book Value Ratio|Daxor (DXR) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio MDAI (Spectral AI, Inc.)|Market-to-Book Ratio organovo.com|Market Capitalization to Book Value Ratio Aclarion ACON|Capitalization to Book Value Ratio akoyabio.com (AKYA)|Market Capitalization to Book Value Ratio THMO|Market Capitalization to Book Value Talis Biomedical Corp. TLIS|TTOO: Market Capitalization to Book Value Ratio